| ARe we there yet? Understanding androgen receptor signaling in breast cancer AR Michmerhuizen, DE Spratt, LJ Pierce, CW Speers NPJ breast cancer 6 (1), 47, 2020 | 78 | 2020 |
| TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination BC Chandler, L Moubadder, CL Ritter, M Liu, M Cameron, ... The Journal of clinical investigation 130 (2), 958-973, 2020 | 56 | 2020 |
| PARP1 inhibition radiosensitizes models of inflammatory breast cancer to ionizing radiation AR Michmerhuizen, AM Pesch, L Moubadder, BC Chandler, ... Molecular cancer therapeutics 18 (11), 2063-2073, 2019 | 48 | 2019 |
| Short-term CDK4/6 inhibition radiosensitizes estrogen receptor–positive breast cancers AM Pesch, NH Hirsh, BC Chandler, AR Michmerhuizen, CL Ritter, ... Clinical Cancer Research 26 (24), 6568-6580, 2020 | 32 | 2020 |
| Seviteronel, a novel CYP17 lyase inhibitor and androgen receptor antagonist, radiosensitizes AR-positive triple negative breast cancer cells AR Michmerhuizen, B Chandler, E Olsen, K Wilder-Romans, ... Frontiers in endocrinology 11, 35, 2020 | 29 | 2020 |
| A signature that may be predictive of early versus late recurrence after radiation treatment for breast cancer that may inform the biology of early, aggressive recurrences C Speers, SL Chang, A Pesch, C Ritter, E Olsen, B Chandler, ... International Journal of Radiation Oncology* Biology* Physics 108 (3), 686-696, 2020 | 12 | 2020 |
| RB expression confers sensitivity to CDK4/6 inhibitor–mediated radiosensitization across breast cancer subtypes AM Pesch, NH Hirsh, AR Michmerhuizen, KM Jungles, K Wilder-Romans, ... JCI insight 7 (3), 2022 | 11 | 2022 |
| Radius ratio rule rescue A Michmerhuizen, K Rose, W Annankra, DA Vander Griend Journal of Chemical Education 94 (10), 1480-1485, 2017 | 10 | 2017 |
| Estrogen receptor inhibition mediates radiosensitization of ER-positive breast cancer models AR Michmerhuizen, LM Lerner, AM Pesch, C Ward, R Schwartz, ... NPJ Breast Cancer 8 (1), 31, 2022 | 7 | 2022 |
| Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression AM Pesch, BC Chandler, AR Michmerhuizen, HM Carter, NH Hirsh, ... Cancer research communications 2 (7), 679-693, 2022 | 5 | 2022 |
| Sensitivity limits for determining 1: 1 binding constants from spectrophotometric titrations via global analysis NP Kazmierczak, JA Chew, AR Michmerhuizen, SE Kim, ZD Drees, ... Journal of Chemometrics 33 (5), e3119, 2019 | 5 | 2019 |
| The crystal structure of a valinomycin•2Ca2+ complex and the multi-step solution equilibria in acetonitrile characterised by 1H NMR, UV–Vis, and mass spectrometry AA Contractor, AM Kazerouni, AR Michmerhuizen, ML Falkenberry, ... Supramolecular Chemistry 29 (2), 129-138, 2017 | 5 | 2017 |
| Transcriptomic Analysis to Uncover the Mechanism of Radiosensitization of AR-Positive Triple Negative Breast Cancers with AR Inhibition CE Pisano, B McBean, AR Michmerhuizen, B Chandler, A Pesch, C Ward, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), e255, 2023 | 1 | 2023 |
| Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer AR Michmerhuizen, LM Lerner, C Ward, AM Pesch, A Zhang, R Schwartz, ... British Journal of Cancer 127 (5), 927-936, 2022 | 1 | 2022 |
| Degrading AR-dependent cancers: Expanding the role of PROTACs AR Michmerhuizen, C Speers Neoplasia (New York, NY) 22 (10), 533, 2020 | 1 | 2020 |
| PARP inhibition as a radiosensitizing strategy to improve locoregional control in inflammatory breast cancer A Michmerhuizen, A Pesch, L Moubadder, M Cameron, A Zhang, N Hirsh, ... Cancer Research 79 (13_Supplement), 3924-3924, 2019 | 1 | 2019 |
| Mechanisms of Intrinsic Radioresistance in Breast Cancer Identify Potential Therapeutic Vulnerabilities B McBean, AR Michmerhuizen, K Wilder-Romans, B Chandler, L Lerner, ... International Journal of Radiation Oncology, Biology, Physics 117 (2), e250, 2023 | | 2023 |
| Molecular mechanisms of intrinsic radioresistance in breast cancer BN McBean, AR Michmerhuizen, K Wilder-Romans, BC Chandler, ... Cancer Research 83 (7_Supplement), 2401-2401, 2023 | | 2023 |
| MDM2 inhibition as a non-hormone dependent radiosensitizing strategy in p53 wild-type breast cancer models CA Nino, CL Ritter, AM Pesch, AR Michmerhuizen, BC Chandler, Y Kaur, ... Cancer Research 82 (12_Supplement), 215-215, 2022 | | 2022 |
| Multiomics analysis to uncover the mechanism of radiosensitization of AR-positive triple negative breast cancers with AR inhibition AR Michmerhuizen, AM Pesch, BC Chandler, LM Lerner, C Ward, ... Cancer Research 82 (12_Supplement), 3307-3307, 2022 | | 2022 |
